438 results
Page 4 of 22
8-K
EX-10.1
guadsxsmse0gwdcka8
24 Nov 21
Seelos Therapeutics Announces Acquisition of an Exclusive License of iX Biopharma’s Proprietary Wafer-Based Delivery Platform for Sublingual Ketamine
8:20am
8-K
EX-10.2
xdousl or15wmh5
24 Nov 21
Entry into a Material Definitive Agreement
7:27am
8-K
EX-1.1
jbi wikoyau3
21 May 21
Seelos Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
12:00am
424B5
ck5g8nu 4upr
21 May 21
Prospectus supplement for primary offering
12:00am
424B5
oypulv8jqjr4tp8ywn
19 May 21
Prospectus supplement for primary offering
4:08pm
424B5
15idlwxhochu6m5b
26 Jan 21
Prospectus supplement for primary offering
5:11pm
8-K
EX-1.1
vlo93k5r zzb1
26 Jan 21
Seelos Therapeutics Announces Pricing of $31.25 Million Public Offering of Common Stock
5:09pm
424B5
zwpr1 yr8uprq
25 Jan 21
Prospectus supplement for primary offering
4:16pm
UPLOAD
k3a7yfxvvcne8
18 Dec 20
Letter from SEC
12:00am